We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-5.3%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$791M
AUM Growth
-$139M
Cap. Flow
-$89.2M
Cap. Flow %
-11.28%
Top 10 Hldgs %
26.18%
Holding
586
New
64
Increased
133
Reduced
194
Closed
58

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.4%
2 Industrials 14.28%
3 Consumer Staples 5.75%
4 Technology 5.6%
5 Materials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAI
576
DELISTED
Reynolds American Inc
RAI
-548,632
Closed -$22.8M
YHOO
577
CALL
DELISTED
Yahoo Inc
YHOO
-1,000
Closed -$1K
INVN
578
DELISTED
Invensense Inc
INVN
-1,341
Closed -$20.2K
DANG
579
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
-1,606
Closed -$14.4K
WPG
580
DELISTED
Washington Prime Group Inc.
WPG
-9
Closed -$1.05K
OCR
581
DELISTED
OMNICARE INC
OCR
-1
Closed -$94
KRFT
582
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
-5,023
Closed -$428K
CMCSK
583
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
-391,226
Closed -$23.4M

Similar funds

Exane Derivatives's Q3 2015 Portfolio in Review

As of Q3 2015, Exane Derivatives held 586 positions worth $791M, down 15% from $930M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Exane Derivatives withdrew a net $89.2M in Q3 2015, closing 58 positions and reducing 194 holdings. Its most notable exit was HCA Healthcare, an estimated $25.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Exane Derivatives opened a new position in McKesson worth $17.4M.

  • Exane Derivatives's largest Q3 2015 buy was McKesson: 94,079 shares worth $17.4M.
  • Exane Derivatives added most to Eastman Chemical in Q3 2015, an estimated $19M increase.
  • Exane Derivatives's biggest Q3 2015 reduction was Vulcan Materials, cutting an estimated $24.1M.
  • Exane Derivatives fully exited HCA Healthcare in Q3 2015, selling an estimated $25.8M.
  • Exane Derivatives's ten largest holdings make up 26% of its $791M portfolio in Q3 2015.
  • Exane Derivatives opened 64 new positions and closed 58 in Q3 2015.
  • Exane Derivatives's portfolio value fell 15% quarter-over-quarter to $791M.

Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.